Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price was up 1.6% during mid-day trading on Thursday . The company traded as high as $4.44 and last traded at $4.42. Approximately 649,754 shares traded hands during mid-day trading, an increase of 362% from the average daily volume of 140,656 shares. The stock had previously closed at $4.35.
Ono Pharmaceutical Price Performance
The company has a 50 day simple moving average of $4.63 and a 200 day simple moving average of $4.74.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
See Also
- Five stocks we like better than Ono Pharmaceutical
- Overbought Stocks Explained: Should You Trade Them?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What are earnings reports?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
